KING LUTHER CAPITAL MANAGEMENT CORP
Position in HALO — Halozyme Therapeutics, Inc.
CIK 310051
FORT WORTH, TX
Position in HALO
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$4,303,323
-$171,252 QoQ
Shares Held
66,584
+0.1% QoQ
Ownership
0.056%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026KING LUTHER CAPITAL MANAGEMENT CORP holds $9,019,114 across 6 Biotechnology names. HALO ranks #1 (47.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
This page
|
66,584 | $4,303,323 | |
| 2 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
53,725 | $3,368,557 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
948 | $732,462 | |
| 4 | MNKD |
Mannkind Corp
|
138,605 | $339,582 | |
| 5 | ABSI |
Absci Corp
|
77,520 | $232,560 | |
| 6 | RANI |
Rani Therapeutics Holdings, Inc.
|
58,000 | $42,630 |
All Filings in HALO
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,303,323 | 66,584 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $4,474,575 | 66,487 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $4,858,041 | 66,240 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $3,445,804 | 66,240 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $4,226,774 | 66,240 | Shares | Sole | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||